Literature DB >> 17915579

Lafora disease, seizures and sugars.

D M Andrade1, J Turnbull, B A Minassian.   

Abstract

Lafora disease (LD) is the most severe form of Progressive Myoclonus Epilepsy with teenage onset. It has an autosomal recessive mode of inheritance and is almost universally fatal by the second or third decade of life. To date, there is no prevention or cure. In the last decade, with the identification of the genes responsible for this disease, much knowledge has been gained with the potential for the future development of effective treatment. This review will briefly address clinical issues and will focus on the molecular aspects of the disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17915579      PMCID: PMC2949329     

Source DB:  PubMed          Journal:  Acta Myol        ISSN: 1128-2460


  38 in total

1.  Longitudinal clinicoelectrophysiologic study of a case of Lafora disease proven by skin biopsy.

Authors:  K Kobayashi; K Iyoda; Y Ohtsuka; S Ohtahara; M Yamada
Journal:  Epilepsia       Date:  1990 Mar-Apr       Impact factor: 5.864

2.  Novel glycogen synthase kinase 3 and ubiquitination pathways in progressive myoclonus epilepsy.

Authors:  Hannes Lohi; Leonarda Ianzano; Xiao-Chu Zhao; Elayne M Chan; Julie Turnbull; Stephen W Scherer; Cameron A Ackerley; Berge A Minassian
Journal:  Hum Mol Genet       Date:  2005-08-22       Impact factor: 6.150

3.  Mutations in the NHLRC1 gene are the common cause for Lafora disease in the Japanese population.

Authors:  Shweta Singh; Toshimitsu Suzuki; Akira Uchiyama; Satoko Kumada; Nobuko Moriyama; Shinichi Hirose; Yukitoshi Takahashi; Hideo Sugie; Koichi Mizoguchi; Yushi Inoue; Kazue Kimura; Yukio Sawaishi; Kazuhiro Yamakawa; Subramaniam Ganesh
Journal:  J Hum Genet       Date:  2005-07-15       Impact factor: 3.172

4.  Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin.

Authors:  Matthew S Gentry; Carolyn A Worby; Jack E Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-01       Impact factor: 11.205

5.  Lafora progressive Myoclonus Epilepsy mutation database-EPM2A and NHLRC1 (EPM2B) genes.

Authors:  Leonarda Ianzano; Junjun Zhang; Elayne M Chan; Xiao-Chu Zhao; Hannes Lohi; Stephen W Scherer; Berge A Minassian
Journal:  Hum Mutat       Date:  2005-10       Impact factor: 4.878

6.  Nonepileptic visual hallucinations in Lafora disease.

Authors:  D M Andrade; J M del Campo; E Moro; B A Minassian; R A Wennberg
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

7.  Expanded repeat in canine epilepsy.

Authors:  Hannes Lohi; Edwin J Young; Susan N Fitzmaurice; Clare Rusbridge; Elayne M Chan; Mike Vervoort; Julie Turnbull; Xiao-Chu Zhao; Leonarda Ianzano; Andrew D Paterson; Nathan B Sutter; Elaine A Ostrander; Catherine André; G Diane Shelton; Cameron A Ackerley; Stephen W Scherer; Berge A Minassian
Journal:  Science       Date:  2005-01-07       Impact factor: 47.728

8.  Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy.

Authors:  B A Minassian; J R Lee; J A Herbrick; J Huizenga; S Soder; A J Mungall; I Dunham; R Gardner; C Y Fong; S Carpenter; L Jardim; P Satishchandra; E Andermann; O C Snead; I Lopes-Cendes; L C Tsui; A V Delgado-Escueta; G A Rouleau; S W Scherer
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

9.  Glycogen and related polysaccharides inhibit the laforin dual-specificity protein phosphatase.

Authors:  Wei Wang; Peter J Roach
Journal:  Biochem Biophys Res Commun       Date:  2004-12-17       Impact factor: 3.575

10.  Clinical and genetic findings in 26 Italian patients with Lafora disease.

Authors:  Silvana Franceschetti; Antonio Gambardella; Laura Canafoglia; Pasquale Striano; Hannes Lohi; Elena Gennaro; Leonarda Ianzano; Pierangelo Veggiotti; Vito Sofia; Roberto Biondi; Salvatore Striano; Cinzia Gellera; Grazia Annesi; Francesca Madia; Donata Civitelli; Francesca E Rocca; Aldo Quattrone; Giuliano Avanzini; Berge Minassian; Federico Zara
Journal:  Epilepsia       Date:  2006-03       Impact factor: 5.864

View more
  14 in total

Review 1.  Are there errors in glycogen biosynthesis and is laforin a repair enzyme?

Authors:  Peter J Roach
Journal:  FEBS Lett       Date:  2011-09-16       Impact factor: 4.124

Review 2.  Glycogen phosphorylation and Lafora disease.

Authors:  Peter J Roach
Journal:  Mol Aspects Med       Date:  2015-08-13

3.  Triacylglycerol mimetics regulate membrane interactions of glycogen branching enzyme: implications for therapy.

Authors:  Rafael Alvarez; Jesús Casas; David J López; Maitane Ibarguren; Ariadna Suari-Rivera; Silvia Terés; Francisca Guardiola-Serrano; Alexander Lossos; Xavier Busquets; Or Kakhlon; Pablo V Escribá
Journal:  J Lipid Res       Date:  2017-06-19       Impact factor: 5.922

4.  Phosphate incorporation during glycogen synthesis and Lafora disease.

Authors:  Vincent S Tagliabracci; Christian Heiss; Chandra Karthik; Christopher J Contreras; John Glushka; Mayumi Ishihara; Parastoo Azadi; Thomas D Hurley; Anna A DePaoli-Roach; Peter J Roach
Journal:  Cell Metab       Date:  2011-03-02       Impact factor: 27.287

5.  Skeletal Muscle Glycogen Chain Length Correlates with Insolubility in Mouse Models of Polyglucosan-Associated Neurodegenerative Diseases.

Authors:  Mitchell A Sullivan; Silvia Nitschke; Evan P Skwara; Peixiang Wang; Xiaochu Zhao; Xiao S Pan; Erin E Chown; Travis Wang; Ami M Perri; Jennifer P Y Lee; Francisco Vilaplana; Berge A Minassian; Felix Nitschke
Journal:  Cell Rep       Date:  2019-04-30       Impact factor: 9.423

Review 6.  [Lafora disease: a review of the literature].

Authors:  L Desdentado; R Espert; P Sanz; J Tirapu-Ustarroz
Journal:  Rev Neurol       Date:  2019-01-16       Impact factor: 0.870

Review 7.  Glycogen and its metabolism: some new developments and old themes.

Authors:  Peter J Roach; Anna A Depaoli-Roach; Thomas D Hurley; Vincent S Tagliabracci
Journal:  Biochem J       Date:  2012-02-01       Impact factor: 3.857

8.  Starch binding domain-containing protein 1/genethonin 1 is a novel participant in glycogen metabolism.

Authors:  Sixin Jiang; Brigitte Heller; Vincent S Tagliabracci; Lanmin Zhai; Jose M Irimia; Anna A DePaoli-Roach; Clark D Wells; Alexander V Skurat; Peter J Roach
Journal:  J Biol Chem       Date:  2010-09-01       Impact factor: 5.157

9.  Structural basis for 2'-phosphate incorporation into glycogen by glycogen synthase.

Authors:  Vimbai M Chikwana; May Khanna; Sulochanadevi Baskaran; Vincent S Tagliabracci; Christopher J Contreras; Anna DePaoli-Roach; Peter J Roach; Thomas D Hurley
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-09       Impact factor: 11.205

10.  Muscle glycogen remodeling and glycogen phosphate metabolism following exhaustive exercise of wild type and laforin knockout mice.

Authors:  Jose M Irimia; Vincent S Tagliabracci; Catalina M Meyer; Dyann M Segvich; Anna A DePaoli-Roach; Peter J Roach
Journal:  J Biol Chem       Date:  2015-07-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.